FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2344316789> ?p ?o ?g. }

• W2344316789 endingPage "31214" @default.
• W2344316789 startingPage "31204" @default.
• W2344316789 abstract "// Sung Yong Oh 1 , Aesun Shin 2 , Seong-Geun Kim 3 , Jung-Ah Hwang 4 , Seung Hyun Hong 4 , Yeon-Su Lee 4 , Hyuk-Chan Kwon 5 1 Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea 2 Department of Preventive Medicine, Seoul National University, Korea 3 Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea 4 Cancer Genomics Branch, Research Institute, National Cancer Center, Goyang, Gyeonggi-do, Korea 5 Sillajen Inc., Busan, Korea Correspondence to: Yeon-Su Lee, email: yslee2@ncc.re.kr Hyuk-Chan Kwon, email: hckwon@sillajen.com Keywords: insulin-like growth factor, polymorphism, gastric cancer Received: January 08, 2016      Accepted: April 11, 2016      Published: April 29, 2016 ABSTRACT The insulin-like growth factor (IGF) axis plays a crucial role in proliferation, differentiation, migration, angiogenesis, and apoptosis. The present study evaluated the associations between IGF axis single-nucleotide polymorphisms (SNPs) and clinical outcomes in advanced gastric cancer (AGC) patients treated with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX). A total of 190 patients undergoing FOLFOX chemotherapy for AGC were considered eligible for this study. Forty-four SNPs of 10 IGF axis genes were genotyped. Levels of serum IGF1 were measured using enzyme-linked immunoassays. SNPs of the IGF1R (rs12423791), and IGF1 (rs2162679, rs5742612, rs35767) genes were significantly associated with tumor response to FOLFOX. SNPs of rs4619 and rs17847203 were significantly associated with PFS (hazard ratio [HR] 0.575, 95% CI 0.385–0.858, P = 0.007; and HR 2.530, 95% CI 1.289–4.966, P = 0.007; respectively). SNPs of rs2872060 were significantly associated with OS—OS was shorter in patients carrying the TT variant than in those with the GG/GT genotypes (HR, 1.708, 95% CI 1.024–2.850, P = 0.040). The GT genotype of rs12847203 was also identified as an independent prognostic factor (HR 2.087, 95% CI 1.070–4.069, P = 0.031). These results suggest that IGF axis-pathway SNPs could be used as prognostic biomarkers of the outcome of FOLFOX chemotherapy in AGC patients. This information may facilitate identification of population subgroups that could benefit from IGF1R-targeted agents." @default.
• W2344316789 created "2016-06-24" @default.
• W2344316789 creator A5004454668 @default.
• W2344316789 creator A5016749298 @default.
• W2344316789 creator A5033050173 @default.
• W2344316789 creator A5063392292 @default.
• W2344316789 creator A5075932421 @default.
• W2344316789 creator A5084350774 @default.
• W2344316789 creator A5084971825 @default.
• W2344316789 date "2016-04-29" @default.
• W2344316789 modified "2023-09-24" @default.
• W2344316789 title "Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX" @default.
• W2344316789 cites W103954886 @default.
• W2344316789 cites W1827870815 @default.
• W2344316789 cites W1992048053 @default.
• W2344316789 cites W1993999038 @default.
• W2344316789 cites W2000776621 @default.
• W2344316789 cites W2007187980 @default.
• W2344316789 cites W2012465024 @default.
• W2344316789 cites W2018020430 @default.
• W2344316789 cites W2019607817 @default.
• W2344316789 cites W2021221959 @default.
• W2344316789 cites W2038565970 @default.
• W2344316789 cites W2043399936 @default.
• W2344316789 cites W2043757866 @default.
• W2344316789 cites W2050436485 @default.
• W2344316789 cites W2088636164 @default.
• W2344316789 cites W2089171551 @default.
• W2344316789 cites W2091462887 @default.
• W2344316789 cites W2098132334 @default.
• W2344316789 cites W2125110875 @default.
• W2344316789 cites W2126430769 @default.
• W2344316789 cites W2127812467 @default.
• W2344316789 cites W2128412799 @default.
• W2344316789 cites W2130884130 @default.
• W2344316789 cites W2160868175 @default.
• W2344316789 cites W2162530578 @default.
• W2344316789 cites W2337162728 @default.
• W2344316789 cites W2365841274 @default.
• W2344316789 cites W2917837889 @default.
• W2344316789 cites W2917869996 @default.
• W2344316789 doi "https://doi.org/10.18632/oncotarget.9100" @default.
• W2344316789 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5058750" @default.
• W2344316789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27144430" @default.
• W2344316789 hasPublicationYear "2016" @default.
• W2344316789 type Work @default.
• W2344316789 sameAs 2344316789 @default.
• W2344316789 citedByCount "10" @default.
• W2344316789 countsByYear W23443167892017 @default.
• W2344316789 countsByYear W23443167892018 @default.
• W2344316789 countsByYear W23443167892021 @default.
• W2344316789 countsByYear W23443167892022 @default.
• W2344316789 countsByYear W23443167892023 @default.
• W2344316789 crossrefType "journal-article" @default.
• W2344316789 hasAuthorship W2344316789A5004454668 @default.
• W2344316789 hasAuthorship W2344316789A5016749298 @default.
• W2344316789 hasAuthorship W2344316789A5033050173 @default.
• W2344316789 hasAuthorship W2344316789A5063392292 @default.
• W2344316789 hasAuthorship W2344316789A5075932421 @default.
• W2344316789 hasAuthorship W2344316789A5084350774 @default.
• W2344316789 hasAuthorship W2344316789A5084971825 @default.
• W2344316789 hasBestOaLocation W23443167891 @default.
• W2344316789 hasConcept C104317684 @default.
• W2344316789 hasConcept C121608353 @default.
• W2344316789 hasConcept C126322002 @default.
• W2344316789 hasConcept C135763542 @default.
• W2344316789 hasConcept C143998085 @default.
• W2344316789 hasConcept C153209595 @default.
• W2344316789 hasConcept C170493617 @default.
• W2344316789 hasConcept C2775960820 @default.
• W2344316789 hasConcept C2778260052 @default.
• W2344316789 hasConcept C2780689927 @default.
• W2344316789 hasConcept C2780962732 @default.
• W2344316789 hasConcept C526805850 @default.
• W2344316789 hasConcept C54355233 @default.
• W2344316789 hasConcept C71924100 @default.
• W2344316789 hasConcept C86803240 @default.
• W2344316789 hasConceptScore W2344316789C104317684 @default.
• W2344316789 hasConceptScore W2344316789C121608353 @default.
• W2344316789 hasConceptScore W2344316789C126322002 @default.
• W2344316789 hasConceptScore W2344316789C135763542 @default.
• W2344316789 hasConceptScore W2344316789C143998085 @default.
• W2344316789 hasConceptScore W2344316789C153209595 @default.
• W2344316789 hasConceptScore W2344316789C170493617 @default.
• W2344316789 hasConceptScore W2344316789C2775960820 @default.
• W2344316789 hasConceptScore W2344316789C2778260052 @default.
• W2344316789 hasConceptScore W2344316789C2780689927 @default.
• W2344316789 hasConceptScore W2344316789C2780962732 @default.
• W2344316789 hasConceptScore W2344316789C526805850 @default.
• W2344316789 hasConceptScore W2344316789C54355233 @default.
• W2344316789 hasConceptScore W2344316789C71924100 @default.
• W2344316789 hasConceptScore W2344316789C86803240 @default.
• W2344316789 hasIssue "21" @default.
• W2344316789 hasLocation W23443167891 @default.
• W2344316789 hasLocation W23443167892 @default.
• W2344316789 hasLocation W23443167893 @default.
• W2344316789 hasLocation W23443167894 @default.
• W2344316789 hasOpenAccess W2344316789 @default.

• next